Evaluation
*
Strongly disagreeDisagreeSlightly disagreeNeitherSlightly agreeAgreeStrongly agree
The activity presented balanced, evidence-based content free of commercial bias.
The presenter(s) used an effective teaching strategy.
The presentation slides / digital materials / resources and handouts were high quality.
The content was relevant to / useful for my professional practice.
The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care.
The overall quality of the educational activity was excellent.
*
Strongly disagreeDisagreeSlightly disagreeNeitherSlightly agreeAgreeStrongly agree
Explain GLP-1 and GIP receptor sites and actions.
List GLP-1RA and GIP/GLP-1RA agents and their FDA approved indications.
Discuss outcomes data on GLP-1RA and GIP/GLP1-RA agents.
Discuss potential indications for GLP-1RA and GIP/GLP1-RA agents beyond currently FDA approved indications.
*
*
*
*
*
*
*